143 related articles for article (PubMed ID: 37940813)
1. Machine learning applied in patient-reported outcome research-exploring symptoms in adjuvant treatment of breast cancer.
Pappot H; Björnsson BP; Krause O; Bæksted C; Bidstrup PE; Dalton SO; Johansen C; Knoop A; Vogelius I; Holländer-Mieritz C
Breast Cancer; 2024 Jan; 31(1):148-153. PubMed ID: 37940813
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
3. Protocol for the ASTRO study (SSOP-01): a multicentre prospective cohort study investigating adverse events based on electronic patient-reported outcomes in patients with breast cancer after adjuvant chemotherapy.
Kuniyoshi O; Sano M; Nakano Y; Kawaguchi T; Hatakeyama T; Tsuchiya Y; Inada Y; Harada T; Kurosaki M; Mashiko T; Miyaji T; Yamaguchi T
BMJ Open; 2023 Sep; 13(9):e071500. PubMed ID: 37709306
[TBL] [Abstract][Full Text] [Related]
4. Computational prediction of multidisciplinary team decision-making for adjuvant breast cancer drug therapies: a machine learning approach.
Lin FP; Pokorny A; Teng C; Dear R; Epstein RJ
BMC Cancer; 2016 Dec; 16(1):929. PubMed ID: 27905893
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
6. Long-term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy.
Bennedsgaard K; Ventzel L; Themistocleous AC; Bennett DL; Jensen AB; Jensen AR; Andersen NT; Jensen TS; Tankisi H; Finnerup NB
Cancer Med; 2020 Jul; 9(14):5114-5123. PubMed ID: 32469145
[TBL] [Abstract][Full Text] [Related]
7. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a patient-specific predictive instrument for the need for dose reduction in chemotherapy for breast cancer: a potential decision aid for the use of myeloid growth factors.
Savvides P; Terrin N; Erban J; Selker HP
Support Care Cancer; 2003 May; 11(5):313-20. PubMed ID: 12720075
[TBL] [Abstract][Full Text] [Related]
9. The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer.
Quinten C; Kenis C; Hamaker M; Coolbrandt A; Brouwers B; Dal Lago L; Neven P; Vuylsteke P; Debrock G; Van Den Bulck H; Smeets A; Schöffski P; Bottomley A; Wedding U; Wildiers H
J Geriatr Oncol; 2018 Mar; 9(2):152-162. PubMed ID: 29167064
[TBL] [Abstract][Full Text] [Related]
10. Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer.
Montemurro F; Mittica G; Cagnazzo C; Longo V; Berchialla P; Solinas G; Culotta P; Martinello R; Foresto M; Gallizioli S; Calori A; Grasso B; Volpone C; Bertola G; Parola G; Tealdi G; Giuliano PL; Aglietta M; Ballari AM
JAMA Oncol; 2016 Apr; 2(4):445-52. PubMed ID: 26720497
[TBL] [Abstract][Full Text] [Related]
11. Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies.
Iivanainen S; Ekstrom J; Virtanen H; Kataja VV; Koivunen JP
BMC Med Inform Decis Mak; 2021 Jun; 21(1):205. PubMed ID: 34193140
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced toxicity in patients with early breast cancer.
Wiranata JA; Hutajulu SH; Astari YK; Leo B; Bintoro BS; Hardianti MS; Taroeno-Hariadi KW; Kurnianda J; Purwanto I
PLoS One; 2024; 19(2):e0298928. PubMed ID: 38394281
[TBL] [Abstract][Full Text] [Related]
13. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
Bui KT; Willson ML; Goel S; Beith J; Goodwin A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
[TBL] [Abstract][Full Text] [Related]
14. Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors.
Yeo W; Pang E; Liem GS; Suen JJS; Ng RYW; Yip CCH; Li L; Yip CHW; Mo FKF
Health Qual Life Outcomes; 2020 Feb; 18(1):24. PubMed ID: 32041627
[TBL] [Abstract][Full Text] [Related]
15. An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study.
Matthies LM; Taran FA; Keilmann L; Schneeweiss A; Simoes E; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Lux MP; Schuetz F; Fasching PA; Sohn C; Brucker SY; Graf J; Wallwiener M
J Med Internet Res; 2019 Jan; 21(1):e10004. PubMed ID: 30668517
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol.
Krzyzanowska MK; Julian JA; Powis M; Howell D; Earle CC; Enright KA; Mittmann N; Trudeau ME; Grunfeld E
BMC Cancer; 2019 Sep; 19(1):884. PubMed ID: 31488084
[TBL] [Abstract][Full Text] [Related]
17. Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy.
Takala L; Kuusinen TE; Skyttä T; Kellokumpu-Lehtinen PL; Bärlund M
Clin Breast Cancer; 2021 Jun; 21(3):e252-e270. PubMed ID: 33229222
[TBL] [Abstract][Full Text] [Related]
18. Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial.
Graf J; Sickenberger N; Brusniak K; Matthies LM; Deutsch TM; Simoes E; Plappert C; Keilmann L; Hartkopf A; Walter CB; Hahn M; Engler T; Wallwiener S; Schuetz F; Fasching PA; Schneeweiss A; Brucker SY; Wallwiener M
J Med Internet Res; 2022 Feb; 24(2):e16128. PubMed ID: 35133288
[TBL] [Abstract][Full Text] [Related]
19. Patients' experience of communication and handling of symptomatic adverse events in breast cancer patients receiving adjuvant chemotherapy.
Bæksted CW; Nissen A; Knoop AS; Pappot H
Res Involv Engagem; 2019; 5():36. PubMed ID: 31832240
[TBL] [Abstract][Full Text] [Related]
20. Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Pappot H; Baeksted C; Knoop A; Mitchell SA; Nissen A; Johansen C
Breast J; 2019 Mar; 25(2):269-272. PubMed ID: 30761667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
